|
Home |
About Us |
Leadership |
News |
Contact Us |
About Us |
|
|
|
|
|
|
|
Mission |
|
Affinergy is developing products to improve clinical outcomes for a broad spectrum of patients while delivering safe and effective products for use by surgeons. |
History |
|
Affinergy was spun out of Duke University in 2004 based on technology developed by Daniel Kenan, MD, PhD and Mark Grinstaff, PhD. Additional co-founders include Jonathan Gindes and Peyton Anderson. Affinergy has benefited from the support of the NC Biotechnology Center, the Council for Entrepreneurial Development, the National Institutes of Health, and a talented team of advisors. In 2008, Affinergy began transitioning from a research company to one that is primarily engaged in product development of internal programs. Dr. Bruce Lamb joined Affinergy in 2009 to lead all product development activities as our SVP of R&D. Affinergy currently employs approximately 28 professionals and has an extensive network of consultants and advisors. |
|
Affinergy is grateful to the following institutes for funding its research endeavors: |
|
National Institute of Arthritis and Musculoskeletal and Skin Diseases |
National Institute of Dental and Craniofacial Research |
National Institute of General Medical Sciences |
National Heart, Lung, and Blood Institute |
National Institute of Allergy and Infectious Diseases |
National Institute of Diabetes and Digestive and Kidney Diseases |
National Institute of Neurological Disorders and Stroke |
Career Opportunities |
|
Please note that Affinergy does not work with recruiting agencies
|
|
Current Job Openings: |
|
|
Contact Information: |